Steinberg Global Asset Management »

Neurocrine Biosciences shares owned by Steinberg Global Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Steinberg Global Asset Management from 13F filings

Historical chart of Steinberg Global Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Steinberg Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Steinberg Global Asset Management

Quarter filed Position value Share count Share price at filing
2019-03-31 $1.4M 16k 88.11
2018-12-31 $1.1M 16k 71.43
2018-09-30 $2.8M 23k 122.96
2018-06-30 $1.2M 13k 98.24

More positions owned by Steinberg Global Asset Management

Ishares Tr usa min vo (USMV)
Technology SPDR (XLK)
iShares S&P MidCap 400 Index (IJH)
iShares S&P SmallCap 600 Index (IJR)
iShares Russell 3000 Value Index (IUSV)
Financial Select Sector SPDR (XLF)
iShares Russell 3000 Growth Index (IUSG)
Pepsi (PEP)
Texas Pacific Land Trust
Health Care SPDR (XLV)
Select Sector Spdr Tr Communic etfeqty (XLC)
iShares S&P 500 Growth Index (IVW)
Merck & Co (MRK)
iShares S&P 500 Value Index (IVE)
Markel Corporation (MKL)

View all positions for Steinberg Global Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences